4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0000950170-24-073371
Chief Technical Officer acquired 31,250 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Otero Jose Manuel Chief Technical Officer | 2024-06-12 | Grant or award 10b5-1 | +31,250 | 31,250 | D | ||
| Derivatives | |||||||
| Otero Jose Manuel Chief Technical Officer | 2024-06-12 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +187,500 | 187,500 | D | ||
Loading xslF345X05/ownership.xml…